Methods for detection of rare subpopulations of cells and highly purified composition of cells
AssigneeAstellas Institute for Regenerative Medicine
InventorsIrina Klimanskaya, Roger Gay
Life of this patent
Estimating the term…
Abstract
Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.
Claims19
1-100. (canceled)
A method of producing a population of retinal pigment epithelium (RPE) cells comprising:
- (a) generating a preparation of differentiated RPE cells by culturing pluripotent stem cells in vitro for a sufficient duration for RPE cells to appear;
- (b) isolating an aliquot of cells from the preparation of differentiated RPE cells;
- (c) applying a first stain to the aliquot of cells, wherein the first stain detects alkaline phosphatase activity and comprises an alkaline phosphatase substrate, wherein applying the first stain comprises:
- (i) contacting the aliquot of cells with a cocktail of antibodies that comprises two or more distinct antibodies, wherein the cocktail of antibodies comprises antibodies that, collectively, specifically bind to two or more of Stage-specific embryonic antigen-3 (SSEA-3), SSEA-4, TRA-1-60, TRA-1-81, Nanog, or Rex-1;
- and (ii) contacting the aliquot of cells with a secondary antibody that binds to antibodies of the cocktail of antibodies, wherein the secondary antibody is directly or indirectly coupled to alkaline phosphatase;
- and
- (d) examining the aliquot of cells by microscopic observation for the presence of cells stained by the first stain.
A method of producing a population of retinal pigment epithelium (RPE) cells comprising:
- (a) generating a preparation of differentiated RPE cells by culturing pluripotent stem cells in vitro for a sufficient duration for RPE cells to appear;
- (b) isolating an aliquot of cells from the preparation of differentiated RPE cells;
- (c) applying a first stain to the aliquot of cells, wherein the first stain detects alkaline phosphatase activity and comprises an alkaline phosphatase substrate, wherein applying the first stain comprises:
- (i) contacting the aliquot of cells with a cocktail of antibodies that comprises antibodies that specifically bind to Stage-specific embryonic antigen-4 and antibodies that specifically bind to TRA-1-81;
- and (ii) contacting the aliquot of cells with a secondary antibody that binds to antibodies of the cocktail of antibodies, wherein the secondary antibody is directly or indirectly coupled to alkaline phosphatase;
- and
- (d) examining the aliquot of cells by microscopic observation for the presence of cells stained by the first stain.
A method of producing a population of retinal pigment epithelium (RPE) cells comprising:
- (a) generating a preparation of differentiated RPE cells by culturing pluripotent stem cells in vitro in a differentiation medium for a sufficient duration for RPE cells to appear;
- (b) isolating an aliquot of cells from the preparation of differentiated RPE cells and culturing the aliquot of cells in a stem cell medium and in the absence of feeder cells;
- (c) applying a first stain to the aliquot of cells, wherein the first stain detects alkaline phosphatase activity and comprises an alkaline phosphatase substrate, wherein applying the first stain comprises:
- (i) contacting the aliquot of cells with a cocktail of antibodies that comprises antibodies that specifically bind to Stage-specific embryonic antigen-4 and antibodies that specifically bind to TRA-1-81;
- and (ii) contacting the aliquot of cells with a secondary antibody that binds to antibodies of the cocktail of antibodies, wherein the secondary antibody is directly or indirectly coupled to alkaline phosphatase;
- and
- (d) applying a second stain to the aliquot of cells, wherein applying the second stain comprises contacting the aliquot of cells with an antibody that specifically binds to Oct-4, wherein the antibody that specifically binds to Oct-4 is directly or indirectly coupled to a fluorescent label;
- (e) examining the aliquot of cells by microscopic observation for the presence of cells stained by the first stain and the second stain.
Dependencies are inferred from the claim text.